Pfizer ( PFE 1.46%) made a fortune thanks to its work in the COVID-19 market. In 2022, it became the first company in the ...

Zai Lab and Pfizer have entered a strategic collaboration to commercialise XACDURO (sulbactam-durlobactam), a new ...

Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Zai Lab (“Zai Lab”, NASDAQ: ZLAB; HKEX: 9688) and Pfizer (“Pfizer”, NYSE: PFE) announced today a strategic ...

Zai Lab accelerates innovative drug launches in China through partnerships and expertise, targeting $1.5-$2B revenue by 2028.

The Pfizer lease marks an anomaly in a local life science real estate market that has cooled significantly since the early stages of the pandemic when there was a feverish demand for lab space.

Pfizer has not confirmed Walker's employment ... "Which I suspect is the way that the virus started in Wuhan," referring to the lab leak theory, which Snopes reported on in the past.

Pfizer, however, added that as part of the research ... pathogens new functions that could be harmful if released from a lab. Typically, this has meant experiments in which there is a reasonable ...

The alliance between PostEra and Pfizer over the past three years has already advanced several small-molecule programs, and the AI Lab itself was built on a pre-existing Generative Chemistry ...

This site is home to Pfizer’s growing oncology business and a program that offers lab space and resources to biotech startups. Pfizer’s new lease at Torrey Heights is a significant step down ...

Pfizer has been tapped by Shanghai-based Zai Lab to help market the company’s antibacterial drug Xacduro in mainland China, the partners said Thursday. The companies did not disclose the ...